{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:40:46Z","timestamp":1790044846647,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109\\u20132221\\u2013E\\u2013194\\u2013016\\u2013MY3"],"award-info":[{"award-number":["MOST 109\\u20132221\\u2013E\\u2013194\\u2013016\\u2013MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111\\u20132811\\u2013E\\u2013194\\u2013002"],"award-info":[{"award-number":["111\\u20132811\\u2013E\\u2013194\\u2013002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioadv.2024.214065","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T21:21:00Z","timestamp":1729027260000},"page":"214065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson's disease treatment"],"prefix":"10.1016","volume":"166","author":[{"given":"Jen-Tsung","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2024.214065_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bioadv.2024.214065_bb0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"Neural Transm (Vienna)."},{"key":"10.1016\/j.bioadv.2024.214065_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fneur.2018.00228","article-title":"Modeling Parkinson\u2019s disease in Drosophila: what have we learned for dominant traits?","volume":"9","author":"Xiong","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.07.019","article-title":"Challenges in detecting disease modification in Parkinson\u2019s disease clinical trials","volume":"32","author":"Athauda","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bioadv.2024.214065_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2018.04.005","article-title":"Repurposing sex steroids and related drugs as potential treatment for Parkinson\u2019s disease","volume":"147","author":"Bourque","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioadv.2024.214065_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","article-title":"Metabolic dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism","volume":"133","author":"Anandhan","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bioadv.2024.214065_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bioadv.2024.214065_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2020.06.036","article-title":"Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson\u2019s disease based on DJ-1 deficiency","volume":"158","author":"Solana-Manrique","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioadv.2024.214065_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/cells11030331","article-title":"Metabolic alterations in a Drosophila model of Parkinson\u2019s disease based on DJ-1 deficiency","volume":"11","author":"Solana-Manrique","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bioadv.2024.214065_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71329-8","article-title":"Metabolic alterations in Parkinson\u2019s disease astrocytes","volume":"10","author":"Sonninen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2024.214065_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson\u2019s disease: an introspection of its journey towards precision medicine","volume":"137","author":"Bandres-Ciga","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioadv.2024.214065_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389202914666131210195808","article-title":"Genetic insights into sporadic Parkinson\u2019s disease pathogenesis","volume":"14","author":"Chai","year":"2013","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.bioadv.2024.214065_bb0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bioadv.2024.214065_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnmol.2018.00068","article-title":"Distinct mechanisms of pathogenic DJ-1 mutations in mitochondrial quality control","volume":"11","author":"Strobbe","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0075","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200286R","article-title":"Exploring the link between Parkinson\u2019s disease and type 2 diabetes mellitus in Drosophila","volume":"36","author":"Sanz","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.bioadv.2024.214065_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2024.105637","article-title":"Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus","volume":"163","author":"Kuo","year":"2024","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2024.214065_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/abbi.2001.2388","article-title":"Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation","volume":"391","author":"Stojanovic","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioadv.2024.214065_bb0090","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/nu4111679","article-title":"Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea","volume":"4","author":"Du","year":"2012","journal-title":"Nutrients"},{"key":"10.1016\/j.bioadv.2024.214065_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000328516","article-title":"Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson\u2019s disease","volume":"19","author":"Wu","year":"2011","journal-title":"Neurosignals"},{"key":"10.1016\/j.bioadv.2024.214065_bb0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/biof.1035","article-title":"COX-2 in the neurodegenerative process of Parkinson\u2019s disease","volume":"38","author":"Teismann","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.bioadv.2024.214065_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0225-5","article-title":"NADPH oxidases in Parkinson\u2019s disease: a systematic review","volume":"12","author":"Belarbi","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bioadv.2024.214065_bb0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11357-019-00102-1","article-title":"Fusogenic liposomes effectively deliver resveratrol to the cerebral microcirculation and improve endothelium-dependent neurovascular coupling responses in aged mice","volume":"41","author":"Wiedenhoeft","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.bioadv.2024.214065_bb0120","doi-asserted-by":"crossref","first-page":"H299","DOI":"10.1152\/ajpheart.00744.2013","article-title":"Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase","volume":"306","author":"Toth","year":"2014","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0125","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1007\/s10853-014-8163-x","article-title":"Preparation of alginate\u2013CaCl2 microspheres as resveratrol carriers","volume":"49","author":"Cho","year":"2014","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2005.12.010","article-title":"Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas","volume":"42","author":"Fang","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"\u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2024.214065_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bioadv.2024.214065_bb0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtice.2020.02.017","article-title":"Multiple-component dual-phase solid lipid nanoparticles with conjugated transferrin for formulating antioxidants and nerve growth factor against neuronal apoptosis","volume":"110","author":"Kuo","year":"2020","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2024.214065_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtice.2018.03.003","article-title":"Regulation of human brain vascular pericytes and human astrocytes in a blood\u2013brain barrier model using human brain microvascular endothelial cells: expression of TGF-\u03b21, VEGF, MMP-9 and P-gp","volume":"86","author":"Kuo","year":"2018","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2024.214065_bb0160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0167-577X(02)00803-0","article-title":"The viscosity and zeta potential of bentonite dispersions in presence of anionic surfactants","volume":"57","author":"Yalcin","year":"2002","journal-title":"Mater. Lett."},{"key":"10.1016\/j.bioadv.2024.214065_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11743-010-1239-y","article-title":"Critical micelle concentration and HLB of the sodium oleate\u2013hexadecyltrimethylammonium bromide mixed system","volume":"14","author":"Miraglia","year":"2011","journal-title":"J. Surfactants Deterg."},{"key":"10.1016\/j.bioadv.2024.214065_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.indcrop.2011.11.026","article-title":"Characterization of rosemary essential oil for biodegradable emulsions","volume":"37","author":"Rodriguez-Rojo","year":"2012","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.bioadv.2024.214065_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26480\/amm.02.2019.01.19","article-title":"Effect of surfactant addition on the nanofluids properties: a review","volume":"2","author":"Jehhef","year":"2019","journal-title":"Acta Mech. Malaysia."},{"key":"10.1016\/j.bioadv.2024.214065_bb0180","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1021\/acs.langmuir.0c01104","article-title":"Controlling the pore size and connectivity of alumina-particle-stabilized foams using sodium dodecyl sulfate: role of surfactant concentration","volume":"36","author":"Han","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.bioadv.2024.214065_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymertesting.2019.106183","article-title":"Sodium alginate\/alumina composite biomembrane preparation and performance in DMFC application","volume":"81","author":"Shaari","year":"2020","journal-title":"Polym. Test."},{"key":"10.1016\/j.bioadv.2024.214065_bb0190","first-page":"111","article-title":"Spectral analysis of drug loaded nanoparticles for drug-polymer interactions","volume":"8","author":"Singh","year":"2018","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.bioadv.2024.214065_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112233","article-title":"Glutathione- and apolipoprotein E-grafted liposomes to regulate mitogen-activated protein kinases and rescue neurons in Alzheimer\u2019s disease","volume":"127","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2024.214065_bb0200","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1021\/jf062127z","article-title":"Physicochemical properties of alginate\/polycaprolactone-based films containing essential oils","volume":"54","author":"Salmieri","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioadv.2024.214065_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carbpol.2017.11.030","article-title":"The development of an alginate\/polycaprolactone composite scaffold for in situ transfection application","volume":"183","author":"Hu","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2024.214065_bb0210","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/app.22278","article-title":"Graft polymerization of styrene on soy protein isolate","volume":"98","author":"Xi","year":"2005","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0215","doi-asserted-by":"crossref","first-page":"14661","DOI":"10.1021\/bi972039v","article-title":"NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase","volume":"36","author":"Harris","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioadv.2024.214065_bb0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/10611860701794353","article-title":"Polymeric nanoparticles for cancer therapy","volume":"16","author":"Parveen","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioadv.2024.214065_bb0225","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.colsurfa.2007.08.005","article-title":"Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers","volume":"315","author":"Han","year":"2008","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioadv.2024.214065_bb0230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.01.003","article-title":"Resveratrol nanoformulations: challenges and opportunities","volume":"479","author":"Summerlin","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2024.214065_bb0235","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.actbio.2020.11.015","article-title":"Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson\u2019s disease therapy","volume":"119","author":"Kuo","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2024.214065_bb0240","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/acsbiomaterials.1c00555","article-title":"Glutathione liposomes carrying ceftriaxone, FK506, and nilotinib to control overexpressed dopamine markers and apoptotic factors in neurons","volume":"7","author":"Kuo","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioadv.2024.214065_bb0245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","article-title":"Niosomes: a controlled and novel drug delivery system","volume":"34","author":"Rajera","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioadv.2024.214065_bb0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0169-409X(01)00116-8","article-title":"Mathematical modeling of controlled drug delivery","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2024.214065_bb0260","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1115\/1.4010337","article-title":"A statistical distribution function of wide applicability","volume":"18","author":"Weibull","year":"1951","journal-title":"J. Appl. Mech."},{"key":"10.1016\/j.bioadv.2024.214065_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1271\/bbb.90549","article-title":"Evaluation of resveratrol oxidation in vitro and the crucial role of bicarbonate ions","volume":"74","author":"Yang","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bioadv.2024.214065_bb0270","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0006-2952(01)00775-4","article-title":"Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production","volume":"62","author":"Gao","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0275","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/carcin\/bgs283","article-title":"Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioadv.2024.214065_bb0280","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/la2042058","article-title":"Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types","volume":"28","author":"Suresh","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.bioadv.2024.214065_bb0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/2225-4110.110423","article-title":"Camptothecin-loaded liposomes with \u03b1-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural product","volume":"3","author":"Lin","year":"2013","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.bioadv.2024.214065_bb0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.bioadv.2024.214065_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-28-96","article-title":"Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use","volume":"28","author":"Berardi","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioadv.2024.214065_bb0300","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2008.11.100","article-title":"Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis","volume":"1254","author":"Hoffman","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bioadv.2024.214065_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.bioadv.2024.214065_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.0.CO;2-F","article-title":"Multiple domains of occludin are involved in the regulation of paracellular permeability","volume":"78","author":"Balda","year":"2000","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioadv.2024.214065_bb0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015011592","article-title":"Polymeric drug-delivery systems: role in P-gp efflux system inhibition","volume":"32","author":"Gupta","year":"2015","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.bioadv.2024.214065_bb0320","doi-asserted-by":"crossref","first-page":"33324","DOI":"10.1074\/jbc.M113.483487","article-title":"Methamphetamine-induced occludin endocytosis is mediated by the Arp2\/3 complex-regulated actin rearrangement","volume":"288","author":"Park","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioadv.2024.214065_bb0325","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2741\/4267","article-title":"Resveratrol in epilepsy: preventive or treatment opportunities?","volume":"19","author":"Pallas","year":"2014","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11121843","article-title":"The blood\u2013brain barrier and pharmacokinetic\/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults","volume":"11","author":"Haddad","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioadv.2024.214065_bb0335","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2019.03.043","article-title":"Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice","volume":"367","author":"Liu","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioadv.2024.214065_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pathophys.2017.02.001","article-title":"Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats","volume":"24","author":"Kaur","year":"2017","journal-title":"Pathophysiology"},{"key":"10.1016\/j.bioadv.2024.214065_bb0345","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson\u2019s disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioadv.2024.214065_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052322","article-title":"Dopamine transporter loss in 6-OHDA Parkinson\u2019s model is unmet by parallel reduction in dopamine uptake","volume":"7","author":"Chotibut","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bioadv.2024.214065_bb0355","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1021\/bi000493k","article-title":"Reversing the substrate specificities of phenylalanine and tyrosine hydroxylase: aspartate 425 of tyrosine hydroxylase is essential for L-DOPA formation","volume":"39","author":"Daubner","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioadv.2024.214065_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2020.11.004","article-title":"Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice","volume":"42","author":"Kwiatkowski","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0365","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s12035-013-8598-0","article-title":"Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson\u2019s model","volume":"49","author":"Chotibut","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0370","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.11.020","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production","volume":"253","author":"Jung","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0375","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12640-013-9439-7","article-title":"Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization","volume":"25","author":"Renaud","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bioadv.2024.214065_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/937568","article-title":"Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain","volume":"2014","author":"Amin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2024.214065_bb0385","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/bj3330291","article-title":"The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival","volume":"333","author":"Wang","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioadv.2024.214065_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112361","article-title":"Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson\u2019s disease treatment","volume":"129","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2024.214065_bb0395","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-6990-6_9","article-title":"Western blot techniques","volume":"1606","author":"Kim","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0400","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson\u2019s disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/919058","article-title":"Neuroprotective effects of alpha-mangostin on MPP+-induced apoptotic cell death in neuroblastoma SH-SY5Y cells","volume":"2015","author":"Janhom","year":"2015","journal-title":"J. Toxicol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0410","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuro.2014.05.009","article-title":"Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson\u2019s disease in rats","volume":"44","author":"Bisht","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bioadv.2024.214065_bb0415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bioadv.2024.214065_bb0420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","article-title":"Alpha-synuclein biology in Lewy body diseases","volume":"6","author":"Kim","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bioadv.2024.214065_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2017.08.001","article-title":"Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL","volume":"85","author":"McDowall","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bioadv.2024.214065_bb0430","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00415-011-6145-3","article-title":"Progress in Alzheimer\u2019s disease","volume":"259","author":"Galimberti","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.bioadv.2024.214065_bb0435","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-2009-0960","article-title":"Accumulated amyloid-\u03b2 peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer\u2019s disease","volume":"16","author":"Huang","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bioadv.2024.214065_bb0440","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1021\/bi050402p","article-title":"Disruption of the interaction of \u03b1-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter","volume":"44","author":"Wersinger","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioadv.2024.214065_bb0445","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/NDT.S235562","article-title":"Phosphorylation of tau and \u03b1-synuclein induced neurodegeneration in MPTP mouse model of Parkinson\u2019s disease","volume":"16","author":"Hu","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bioadv.2024.214065_bb0450","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41419-018-0848-7","article-title":"Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson\u2019s disease","volume":"9","author":"Milanese","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioadv.2024.214065_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2024.105401","article-title":"Nanocarriers to mediate the pathways from diabetes toward Parkinson\u2019s disease","volume":"157","author":"De","year":"2024","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioadv.2024.214065_bb0460","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753425913488429","article-title":"Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson\u2019s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses","volume":"20","author":"Lofrumento","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.bioadv.2024.214065_bb0465","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotech"},{"key":"10.1016\/j.bioadv.2024.214065_bb0470","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nature Mater."},{"key":"10.1016\/j.bioadv.2024.214065_bb0475","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biopha.2020.110234","article-title":"The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway","volume":"127","author":"Farkhondeh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioadv.2024.214065_bb0480","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S347187","article-title":"Nanoparticles in combating neuronal dysregulated signaling pathways: recent approaches to the nanoformulations of phytochemicals and synthetic drugs against neurodegenerative diseases","volume":"17","author":"Fakhri","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2024.214065_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2021.11.009","article-title":"Rabies virus glycoprotein- and transferrin-functionalized liposomes to elevate epigallocatechin gallate and FK506 activity and mediate MAPK against neuronal apoptosis in Parkinson\u2019s disease","volume":"132","author":"Kuo","year":"2022","journal-title":"J. Taiwan Inst. Chem. Eng."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082400308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082400308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:30:13Z","timestamp":1778934613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277295082400308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":97,"alternative-id":["S277295082400308X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.214065","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson's disease treatment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.214065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214065"}}